The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system

Yang, Zheng; Yu, Meng; Mei, Mei; Chen, Chongxin; Lv, Yuhuan; Xiang, Linyu; Li, Rong

doi:10.1016/j.numecd.2021.10.003

The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system

BACKGROUND AND AIMS In 2019, the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) and food and drug administration (FDA) of the United States of America (US) suggested that the relationship between glucagon-like peptide-1 receptor agonists (GLP-1RA) and diabet…